We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NEO market cap is 2.3B. The company's latest EPS is USD -0.6853 and P/E is -26.38.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 151.95M | 155.55M | 156.24M | 164.5M | 167.82M |
| Operating Income | -24.2M | -18.57M | -30.57M | -21.94M | -21.2M |
| Net Income | -18.52M | -14.33M | -27.06M | -18.64M | -17.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 408.83M | 444.45M | 484.33M | 509.73M | 591.64M |
| Operating Income | 13.01M | -13.99M | -118.75M | -157.62M | -107.74M |
| Net Income | 8.01M | 4.17M | -8.35M | -144.25M | -87.97M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.68B | 1.68B | 1.64B | 1.64B | 1.64B |
| Total Liabilities | 730.81M | 739.69M | 716.93M | 727.39M | 732.9M |
| Total Equity | 947.43M | 941.54M | 923.41M | 915.88M | 908.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 709.51M | 988.33M | 1.87B | 1.74B | 1.68B |
| Total Liabilities | 202.1M | 294.04M | 761.5M | 742.01M | 739.69M |
| Total Equity | 507.41M | 694.29M | 1.11B | 998.02M | 941.54M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.74M | -1.95M | -25.92M | -12.02M | -2.78M |
| Investing | 59.51M | 76.71M | 14.53M | 21.84M | 18.32M |
| Financing | 3.28M | 4.55M | 816k | 2.78M | 3.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 23.37M | 1.46M | -26.72M | -65.99M | -1.95M |
| Investing | -19.63M | -159.44M | -632.37M | 517k | 76.71M |
| Financing | 159.47M | 235.6M | 725.29M | 11.83M | 4.55M |
| Market Cap | 2.3B |
| Price to Earnings Ratio | -26.38 |
| Price to Sales Ratio | 3.92 |
| Price to Cash Ratio | 6.78 |
| Price to Book Ratio | 2.46 |
| Dividend Yield | - |
| Shares Outstanding | 128.36M |
| Average Volume (1 week) | 484.83k |
| Average Volume (1 Month) | 660.28k |
| 52 Week Change | -4.71% |
| 52 Week High | 21.22 |
| 52 Week Low | 12.775 |
| Spread (Intraday) | 0.03 (0.17%) |
| Company Name | NeoGenomics Inc |
| Address |
112 north curry street carson city, nevada 89703 |
| Website | https://www.neogenomics.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
